Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Establishment Labs Holdings Inc. - Common Shares (NQ:ESTA)

68.31 -4.27 (-5.88%)
Streaming Delayed Price Updated: 10:33 AM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Establishment Labs Holdings Inc. - Common Shares

< Previous 1 2 3 4 5 Next >
News headline image
Establishment Labs to Participate in Two Upcoming Investor Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Reports Record First Quarter 2023 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs to Announce First Quarter 2023 Financial Results on May 8
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Pricing of Public Offering of Common Shares
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Proposed Public Offering of Common Shares
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia Femtech in Japan
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Participation in The Aesthetic Meeting 2023
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Surpasses Three Million Motiva Devices
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Investor Alert: Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 03/16/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Establishment Labs Holdings Inc. 
Via SBWire
News headline image
ESTA INVESTOR NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Establishment Labs Holdings Inc. Investors to Inquire About Securities Class Action Investigation – ESTA
From Rosen Law Firm
Via Business Wire
News headline image
Establishment Labs to Present at the Cowen 43rd Annual Health Care Conference
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech™
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
ESTABLISHMENT LABS ALERT: Bragar Eagel & Squire, P.C. is Investigating Establishment Labs Holdings Inc. on Behalf of Establishment Labs Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Establishment Labs to Participate in 41st Annual J.P. Morgan Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating EyePoint, F45, PROG, and Establishment and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Establishment, Accelerate Diagnostics, Instil and Unisys and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Establishment Labs Reports Third Quarter 2022 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating PROG, Tattooed Chef, and Establishment and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Investor Notice: Investigation over Possible Violations of Securities Laws ↗
San Diego, CA -- (SBWIRE) -- 11/02/2022 -- Establishment Labs Holdings Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Establishment, FIGS, and Accelerate Diagnostics and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.